Related Experiment Videos
Pathophysiology of vein graft failure: a review
1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Insights
Vein bypass grafts are crucial for cardiovascular disease but often fail. This review explores vein graft pathology and therapeutic strategies for intimal hyperplasia and atherosclerosis.
Area of Science:
- Cardiovascular Surgery
- Vascular Biology
- Pathology
Background:
- Vein bypass grafting is essential for treating arterial and venous diseases.
- Graft failure due to intrinsic or extrinsic factors is a significant clinical challenge.
Purpose of the Study:
- To review current knowledge on vein graft histology and pathology.
- To assess endothelial and smooth muscle cell physiology and pharmacology in vein grafts.
- To evaluate research on therapeutic control of vein graft intimal hyperplasia and atherosclerosis.
Main Methods:
- Literature review of venous histology and pathology.
- Analysis of endothelial and smooth muscle cell function.
- Assessment of current research on therapeutic interventions.
Main Results:
- Vein graft failure is multifactorial, involving histological and cellular changes.
- Intimal hyperplasia and accelerated atherosclerosis are key pathological processes.
- Understanding cellular physiology and pharmacology is crucial for therapeutic development.
Conclusions:
- Further research into vein graft pathology and cellular mechanisms is needed.
- Targeted therapeutic strategies are essential to improve long-term graft patency.
- Optimizing vein graft performance requires a comprehensive understanding of underlying biological processes.
Abstract:
Vein bypass grafting is an integral component of cardiovascular surgical practice for both arterial and venous diseases. However, many of these grafts will eventually fail due to either intrinsic or extrinsic causes. This review examines the current understanding and knowledge of venous histology, vein graft pathology and the associated endothelial and smooth muscle cell physiology and pharmacology. In addition, the status of research on the therapeutic control of vein graft intimal hyperplasia and accelerated atherosclerosis is assessed.